TrialCancer2015

Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.

Tapan M Kadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.